Cardiff Oncology, Inc. Quarterly Return On Assets in % from Q3 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Cardiff Oncology, Inc. quarterly/annual Return On Assets history and growth rate from Q3 2012 to Q2 2024.
  • Cardiff Oncology, Inc. Return On Assets for the quarter ending June 30, 2024 was -52.7 %, a 47.5% decline year-over-year.
  • Cardiff Oncology, Inc. annual Return On Assets for 2023 was -44.3 %, a 46% decline from 2022.
  • Cardiff Oncology, Inc. annual Return On Assets for 2022 was -30.3 %, a 51.2% decline from 2021.
  • Cardiff Oncology, Inc. annual Return On Assets for 2021 was -20.1 %, a 43.9% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2024 -52.7 -17 -47.5% Apr 1, 2024 Jun 30, 2024
Q1 2024 -47.1 -14.5 -44.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 -44.3 -14 -46% Oct 1, 2023 Dec 31, 2023
Q3 2023 -39.9 -10.9 -37.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 -35.7 -8.8 -32.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 -32.6 -8.83 -37.1% Jan 1, 2023 Mar 31, 2023
Q4 2022 -30.3 -10.3 -51.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 -29 -10.5 -56.7% Jul 1, 2022 Sep 30, 2022
Q2 2022 -26.9 -6.34 -30.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 -23.8 +0.66 +2.7% Jan 1, 2022 Mar 31, 2022
Q4 2021 -20.1 +15.7 +43.9% Oct 1, 2021 Dec 31, 2021
Q3 2021 -18.5 +53.2 +74.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 -20.6 +78.6 +79.2% Apr 1, 2021 Jun 30, 2021
Q1 2021 -24.4 +107 +81.3% Jan 1, 2021 Mar 31, 2021
Q4 2020 -35.7 +87.2 +70.9% Oct 1, 2020 Dec 31, 2020
Q3 2020 -71.8 +48.1 +40.1% Jul 1, 2020 Sep 30, 2020
Q2 2020 -99.2 +6.36 +6.03% Apr 1, 2020 Jun 30, 2020
Q1 2020 -131 -39.9 -43.7% Jan 1, 2020 Mar 31, 2020
Q4 2019 -123 -20.5 -20% Oct 1, 2019 Dec 31, 2019
Q3 2019 -120 -24.5 -25.7% Jul 1, 2019 Sep 30, 2019
Q2 2019 -106 +3.12 +2.87% Apr 1, 2019 Jun 30, 2019
Q1 2019 -91.1 +74.8 +45.1% Jan 1, 2019 Mar 31, 2019
Q4 2018 -102 +37.9 +27% Oct 1, 2018 Dec 31, 2018
Q3 2018 -95.4 +25 +20.8% Jul 1, 2018 Sep 30, 2018
Q2 2018 -109 -6.07 -5.92% Apr 1, 2018 Jun 30, 2018
Q1 2018 -166 -82.9 -99.9% Jan 1, 2018 Mar 31, 2018
Q4 2017 -140 -69 -96.6% Oct 1, 2017 Dec 31, 2017
Q3 2017 -120 -58.8 -95.5% Jul 1, 2017 Sep 30, 2017
Q2 2017 -103 -57.5 -127% Apr 1, 2017 Jun 30, 2017
Q1 2017 -83 -35.7 -75.3% Jan 1, 2017 Mar 31, 2017
Q4 2016 -71.4 -25.2 -54.6% Oct 1, 2016 Dec 31, 2016
Q3 2016 -61.6 -10.8 -21.4% Jul 1, 2016 Sep 30, 2016
Q2 2016 -45.1 +27.5 +37.8% Apr 1, 2016 Jun 30, 2016
Q1 2016 -47.4 +3.62 +7.1% Jan 1, 2016 Mar 31, 2016
Q4 2015 -46.2 +0.67 +1.43% Oct 1, 2015 Dec 31, 2015
Q3 2015 -50.7 -15.3 -43.2% Jul 1, 2015 Sep 30, 2015
Q2 2015 -72.6 -39.4 -119% Apr 1, 2015 Jun 30, 2015
Q1 2015 -51 +10.5 +17.1% Jan 1, 2015 Mar 31, 2015
Q4 2014 -46.9 +15.2 +24.5% Oct 1, 2014 Dec 31, 2014
Q3 2014 -35.4 +77.5 +68.6% Jul 1, 2014 Sep 30, 2014
Q2 2014 -33.2 +100 +75.1% Apr 1, 2014 Jun 30, 2014
Q1 2014 -61.5 +52.6 +46.1% Jan 1, 2014 Mar 31, 2014
Q4 2013 -62.1 +85.4 +57.9% Oct 1, 2013 Dec 31, 2013
Q3 2013 -113 +12.2 +9.77% Jul 1, 2013 Sep 30, 2013
Q2 2013 -133 Apr 1, 2013 Jun 30, 2013
Q1 2013 -114 Jan 1, 2013 Mar 31, 2013
Q4 2012 -147 Oct 1, 2012 Dec 31, 2012
Q3 2012 -125 Jul 1, 2012 Sep 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.